Compare $KRMD vs $STIM | Chartloom

Compare

$KRMD vs $STIM

KORU Medical Systems Inc · Neuronetics Inc

KRMD

KORU Medical Systems Inc

STIM

Neuronetics Inc

Compare $KRMD vs $STIM

Comparing KORU Medical Systems Inc and Neuronetics Inc

KRMDKORU Medical Systems Inc

STIMNeuronetics Inc

KRMDKORU Medical Systems Inc

Market cap

$136M

P/E (TTM)

—

Forward P/E (NTM)

1,748.17x

Forward P/S (NTM)

2.55x

Rev growth (TTM)

22.4%

YTD performance

-47.2%

52W performance

-29.4%

FCF yield

0.2%

STIMNeuronetics Inc

Market cap

$148M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

0.86x

Rev growth (TTM)

39.6%

YTD performance

47.9%

52W performance

-28.3%

FCF yield

-7.6%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

KRMD

STIM

Detailed metrics comparison

KRMD

KORU Medical Systems Inc

STIM

Neuronetics Inc

Market Cap

KRMD$136M

STIM$148M

Enterprise Value

KRMD$128M

STIM$191M

Price

KRMD$2.96

STIM$2.13

P/E Ratio

KRMDN/A

STIMN/A

P/S Ratio

KRMD3.01x

STIM0.96x

EV/Sales

KRMD2.84x

STIM1.23x

EV/EBITDA

KRMD918.58x

STIM0.00x

P/B Ratio

KRMD7.57x

STIM9.22x

P/FCF Ratio

KRMD559.48x

STIMN/A

EV/FCF

KRMD526.28x

STIM-16.94x

PEG Ratio

KRMDN/A

STIMN/A

Forward P/E (NTM)

KRMD1,748.17x

STIMN/A

Forward P/S (NTM)

KRMD2.55x

STIM0.86x

Revenue (TTM)

KRMD$45M

STIM$155M

Revenue Growth (YoY)

KRMD22.4%

STIM39.6%

Forward Rev Growth

KRMD17.2%

STIM9.3%

Gross Margin (TTM)

KRMD62.4%

STIM49.1%

Operating Margin (TTM)

KRMD0.0%

STIM0.0%

EBITDA Margin (TTM)

KRMD-1.9%

STIM-12.7%

Net Margin (TTM)

KRMD-4.0%

STIM-19.6%

FCF Margin (TTM)

KRMD0.5%

STIM-7.3%

Net Income (TTM)

KRMD$-2M

STIM$-30M

FCF (TTM)

KRMD$243K

STIM$-11M

EPS (TTM)

KRMD-$0.04

STIM-$0.42

ROE (TTM)

KRMD-1063.0%

STIM-15056.0%

ROA (TTM)

KRMD-651.0%

STIM-2238.0%

ROIC (TTM)

KRMD-1045.0%

STIM-3632.0%

Cash

KRMD$8M

STIM$19M

Debt

KRMD$220K

STIM$62M

Net Cash/Debt

KRMD$8M

STIM$-42M

Current Ratio (TTM)

KRMD2.72x

STIM1.88x

Quick Ratio (TTM)

KRMD2.00x

STIM1.46x

Debt/Equity (TTM)

KRMD0.01x

STIM3.45x

Debt/Assets (TTM)

KRMD0.0%

STIM0.0%

Interest Coverage (TTM)

KRMDN/A

STIMN/A

Net Debt/EBITDA (TTM)

KRMD0.00x

STIM0.00x

Beta

KRMD0.52

STIM1.33

52W Performance

KRMD-29.4%

STIM-28.3%

YTD Performance

KRMD-47.2%

STIM47.9%

% from 52W High

KRMD-55.2%

STIM-38.1%

% from 52W Low

KRMD3.5%

STIM166.2%

Asset Turnover (TTM)

KRMD1.61x

STIM1.14x

FCF Yield (TTM)

KRMD0.2%

STIM-7.6%

Earnings Yield (TTM)

KRMD-1.3%

STIM-20.5%

Dividend Yield (TTM)

KRMDN/A

STIMN/A

Rule of 40

KRMD23.0

STIM32.3

EV/GP/RG

KRMD0.25

STIM0.22

Ticker research

View KRMD research View STIM research

Metric	KRMD KORU Medical Systems Inc	STIM Neuronetics Inc
Market & Valuation
Market Cap	$136M	$148M
Enterprise Value	$128M	$191M
Price	$2.96	$2.13
P/E Ratio	N/A	N/A
P/S Ratio	3.01x	0.96x
EV/Sales	2.84x	1.23x
EV/EBITDA	918.58x	0.00x
P/B Ratio	7.57x	9.22x
P/FCF Ratio	559.48x	N/A
EV/FCF	526.28x	-16.94x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	1,748.17x	N/A
Forward P/S (NTM)	2.55x	0.86x
Revenue & Growth
Revenue (TTM)	$45M	$155M
Revenue Growth (YoY)	22.4%	39.6%
Forward Rev Growth	17.2%	9.3%
Profitability
Gross Margin (TTM)	62.4%	49.1%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-1.9%	-12.7%
Net Margin (TTM)	-4.0%	-19.6%
FCF Margin (TTM)	0.5%	-7.3%
Net Income (TTM)	$-2M	$-30M
FCF (TTM)	$243K	$-11M
EPS (TTM)	-$0.04	-$0.42
ROE (TTM)	-1063.0%	-15056.0%
ROA (TTM)	-651.0%	-2238.0%
ROIC (TTM)	-1045.0%	-3632.0%
Financial Health
Cash	$8M	$19M
Debt	$220K	$62M
Net Cash/Debt	$8M	$-42M
Current Ratio (TTM)	2.72x	1.88x
Quick Ratio (TTM)	2.00x	1.46x
Debt/Equity (TTM)	0.01x	3.45x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.52	1.33
52W Performance	-29.4%	-28.3%
YTD Performance	-47.2%	47.9%
% from 52W High	-55.2%	-38.1%
% from 52W Low	3.5%	166.2%
Efficiency & Yields
Asset Turnover (TTM)	1.61x	1.14x
FCF Yield (TTM)	0.2%	-7.6%
Earnings Yield (TTM)	-1.3%	-20.5%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	23.0	32.3
EV/GP/RG	0.25	0.22
Ticker research	View KRMD research	View STIM research

Valuation

P/S Ratio

STIM

0.96x

KRMD

3.01x

EV/FCF

STIM

-16.94x

KRMD

526.28x

Growth & revenue

Revenue Growth TTM

STIM

39.6%

KRMD

22.4%

Forward Revenue Growth

KRMD

17.2%

STIM

9.3%

Profitability & performance

Gross Margin

KRMD

62.4%

STIM

49.1%

ROE

KRMD

-1063.0%

STIM

-15056.0%

FCF Yield %

KRMD

0.2%

STIM

-7.6%

52-Week Performance

STIM

-28.3%

KRMD

-29.4%

Detailed metrics comparison

KRMD

KORU Medical Systems Inc

STIM

Neuronetics Inc

Market Cap

KRMD$136M

STIM$148M

Enterprise Value

KRMD$128M

STIM$191M

Price

KRMD$2.96

STIM$2.13

P/E Ratio

KRMDN/A

STIMN/A

P/S Ratio

KRMD3.01x

STIM0.96x

EV/Sales

KRMD2.84x

STIM1.23x

EV/EBITDA

KRMD918.58x

STIM0.00x

P/B Ratio

KRMD7.57x

STIM9.22x

P/FCF Ratio

KRMD559.48x

STIMN/A

EV/FCF

KRMD526.28x

STIM-16.94x

PEG Ratio

KRMDN/A

STIMN/A

Forward P/E (NTM)

KRMD1,748.17x

STIMN/A

Forward P/S (NTM)

KRMD2.55x

STIM0.86x

Revenue (TTM)

KRMD$45M

STIM$155M

Revenue Growth (YoY)

KRMD22.4%

STIM39.6%

Forward Rev Growth

KRMD17.2%

STIM9.3%

Gross Margin (TTM)

KRMD62.4%

STIM49.1%

Operating Margin (TTM)

KRMD0.0%

STIM0.0%

EBITDA Margin (TTM)

KRMD-1.9%

STIM-12.7%

Net Margin (TTM)

KRMD-4.0%

STIM-19.6%

FCF Margin (TTM)

KRMD0.5%

STIM-7.3%

Net Income (TTM)

KRMD$-2M

STIM$-30M

FCF (TTM)

KRMD$243K

STIM$-11M

EPS (TTM)

KRMD-$0.04

STIM-$0.42

ROE (TTM)

KRMD-1063.0%

STIM-15056.0%

ROA (TTM)

KRMD-651.0%

STIM-2238.0%

ROIC (TTM)

KRMD-1045.0%

STIM-3632.0%

Cash

KRMD$8M

STIM$19M

Debt

KRMD$220K

STIM$62M

Net Cash/Debt

KRMD$8M

STIM$-42M

Current Ratio (TTM)

KRMD2.72x

STIM1.88x

Quick Ratio (TTM)

KRMD2.00x

STIM1.46x

Debt/Equity (TTM)

KRMD0.01x

STIM3.45x

Debt/Assets (TTM)

KRMD0.0%

STIM0.0%

Interest Coverage (TTM)

KRMDN/A

STIMN/A

Net Debt/EBITDA (TTM)

KRMD0.00x

STIM0.00x

Beta

KRMD0.52

STIM1.33

52W Performance

KRMD-29.4%

STIM-28.3%

YTD Performance

KRMD-47.2%

STIM47.9%

% from 52W High

KRMD-55.2%

STIM-38.1%

% from 52W Low

KRMD3.5%

STIM166.2%

Asset Turnover (TTM)

KRMD1.61x

STIM1.14x

FCF Yield (TTM)

KRMD0.2%

STIM-7.6%

Earnings Yield (TTM)

KRMD-1.3%

STIM-20.5%

Dividend Yield (TTM)

KRMDN/A

STIMN/A

Rule of 40

KRMD23.0

STIM32.3

EV/GP/RG

KRMD0.25

STIM0.22

Ticker research

View KRMD research View STIM research

Metric	KRMD KORU Medical Systems Inc	STIM Neuronetics Inc
Market & Valuation
Market Cap	$136M	$148M
Enterprise Value	$128M	$191M
Price	$2.96	$2.13
P/E Ratio	N/A	N/A
P/S Ratio	3.01x	0.96x
EV/Sales	2.84x	1.23x
EV/EBITDA	918.58x	0.00x
P/B Ratio	7.57x	9.22x
P/FCF Ratio	559.48x	N/A
EV/FCF	526.28x	-16.94x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	1,748.17x	N/A
Forward P/S (NTM)	2.55x	0.86x
Revenue & Growth
Revenue (TTM)	$45M	$155M
Revenue Growth (YoY)	22.4%	39.6%
Forward Rev Growth	17.2%	9.3%
Profitability
Gross Margin (TTM)	62.4%	49.1%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-1.9%	-12.7%
Net Margin (TTM)	-4.0%	-19.6%
FCF Margin (TTM)	0.5%	-7.3%
Net Income (TTM)	$-2M	$-30M
FCF (TTM)	$243K	$-11M
EPS (TTM)	-$0.04	-$0.42
ROE (TTM)	-1063.0%	-15056.0%
ROA (TTM)	-651.0%	-2238.0%
ROIC (TTM)	-1045.0%	-3632.0%
Financial Health
Cash	$8M	$19M
Debt	$220K	$62M
Net Cash/Debt	$8M	$-42M
Current Ratio (TTM)	2.72x	1.88x
Quick Ratio (TTM)	2.00x	1.46x
Debt/Equity (TTM)	0.01x	3.45x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.52	1.33
52W Performance	-29.4%	-28.3%
YTD Performance	-47.2%	47.9%
% from 52W High	-55.2%	-38.1%
% from 52W Low	3.5%	166.2%
Efficiency & Yields
Asset Turnover (TTM)	1.61x	1.14x
FCF Yield (TTM)	0.2%	-7.6%
Earnings Yield (TTM)	-1.3%	-20.5%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	23.0	32.3
EV/GP/RG	0.25	0.22
Ticker research	View KRMD research	View STIM research